Wed, February 1, 2023
Tue, January 31, 2023
Mon, January 30, 2023
Sun, January 29, 2023
Fri, January 27, 2023

Graig Suvannavejh Maintained (AXSM) at Strong Buy with Increased Target to $86 on, Jan 30th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-86-on-jan-30th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Graig Suvannavejh of Mizuho, Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Increased Target from $80 to $86 on, Jan 30th, 2023.

Graig has made no other calls on AXSM in the last 4 months.



There are 7 other peers that have a rating on AXSM. Out of the 7 peers that are also analyzing AXSM, 2 agree with Graig's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Amsellem of "Piper Sandler" Initiated at Hold and Held Target at $75 on, Thursday, January 5th, 2023
  • Vikram Purohit of "Morgan Stanley" Maintained at Hold with Increased Target to $86 on, Tuesday, November 29th, 2022


These are the ratings of the 5 analyists that currently disagree with Graig


  • Robert Hazlett of "BTIG" Maintained at Strong Buy with Increased Target to $98 on, Friday, December 23rd, 2022
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $85 on, Tuesday, November 29th, 2022
  • Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Increased Target to $80 on, Friday, November 11th, 2022
  • Esther Hong of "Loop Capital" Initiated at Strong Buy and Held Target at $95 on, Tuesday, November 1st, 2022
  • Chris Howerton of "Jefferies" Maintained at Strong Buy with Decreased Target to $90 on, Friday, September 30th, 2022

Publication Contributing Sources